Society of Urologic Oncology

Society of Urologic Oncology
Name	Society of Urologic Oncology
Abbreviation	SUO
Formation	1984
Type	Professional association
Headquarters	United States
Region served	International
Membership	Urologic oncologists, medical oncologists, radiation oncologists, pathologists

Contents

Society of Urologic Oncology The Society of Urologic Oncology is a professional association focused on urologic oncology, bringing together specialists in uro-oncology from institutions such as Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Dana-Farber Cancer Institute, and MD Anderson Cancer Center to advance care for diseases like prostate cancer, bladder cancer, and kidney cancer. The society interfaces with organizations including the American Urological Association, Society of Surgical Oncology, American Society of Clinical Oncology, and European Association of Urology to coordinate education, research, and guideline development.

History

The organization originated in the mid-1980s with founding figures drawn from centers such as Roswell Park Comprehensive Cancer Center, Cleveland Clinic, University of California, San Francisco, Yale School of Medicine, and Columbia University Irving Medical Center, following initiatives similar to those by National Cancer Institute committees and panels like the National Comprehensive Cancer Network. Early annual meetings paralleled scientific gatherings at American Association for Cancer Research, European Society for Medical Oncology, and Society for Basic Urologic Research, while historical influences included collaborative models from American College of Surgeons and Royal College of Surgeons. Over decades the society evolved alongside registry projects exemplified by Surveillance, Epidemiology, and End Results Program, clinical trials from North Central Cancer Treatment Group, and translational programs at Fred Hutchinson Cancer Center.

The society’s mission emphasizes multidisciplinary care involving clinicians from Brigham and Women’s Hospital, Hospital of the University of Pennsylvania, Stanford Health Care, University of Michigan Health System, and international centers such as Gustave Roussy and Royal Marsden Hospital. Membership categories include practicing surgeons from Massachusetts General Hospital, medical oncologists from City of Hope National Medical Center, radiation oncologists from Memorial Sloan Kettering Cancer Center, pathologists from Mayo Clinic, and trainees from programs like Johns Hopkins School of Medicine and UCLA David Geffen School of Medicine. The society also engages allied professionals from American Board of Urology, European Society for Radiotherapy and Oncology, and patient advocacy groups such as American Cancer Society and Prostate Cancer Foundation.

Governance follows a board structure with officers elected by members representing academic centers including Vanderbilt University Medical Center, Northwestern Memorial Hospital, Mount Sinai Hospital, University of Toronto, and Karolinska Institutet. Leadership roles have been held by clinicians affiliated with University of California, Los Angeles, University of Washington, Duke University School of Medicine, University of Chicago Medical Center, and University College London Hospitals. The society’s committees mirror structures seen in Joint Commission, Institute of Medicine panels, and specialty boards like American Board of Medical Specialties, coordinating programmatic work with groups such as Clinical Trials Cooperative Group and regulatory liaisons including Food and Drug Administration advisory committees.

The society contributes to clinical guidelines and research prioritization through consensus statements similar to those produced by National Comprehensive Cancer Network, randomized trials partnered with European Organisation for Research and Treatment of Cancer, and registries modeled on Cancer Research UK data platforms. Members publish in journals such as Journal of Clinical Oncology, European Urology, Lancet Oncology, New England Journal of Medicine, and Nature Medicine, and contribute to guideline panels including representatives from American Urological Association, National Cancer Institute, Centers for Disease Control and Prevention, American Society of Clinical Oncology, and European Association of Urology. Research collaborations include genomic studies with Broad Institute, biomarker initiatives with Genentech, immunotherapy trials in partnership with Merck & Co., and outcomes research tied to datasets like SEER-Medicare.

The society recognizes contributions through awards named and modeled similarly to prizes from American Cancer Society, Prostate Cancer Foundation, Susan G. Komen Foundation, and honors akin to fellowships from Royal Society and medals from American Surgical Association. Recipients often hail from institutions including Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, University of California, San Francisco, and Stanford University School of Medicine, and may also receive broader recognition from organizations such as National Institutes of Health, Howard Hughes Medical Institute, European Research Council, and national academies like Institute of Medicine.

Collaborative partnerships extend to professional bodies like American Urological Association, Society of Surgical Oncology, American Society of Clinical Oncology, European Association of Urology, and patient-focused organizations such as Prostate Cancer Foundation and Zero Prostate Cancer. Advocacy work engages policymakers and funders including National Institutes of Health, Department of Health and Human Services, Centers for Medicare & Medicaid Services, and international entities like World Health Organization, while joint initiatives involve academic consortia such as Translational Research Working Group and networks resembling Alliance for Clinical Trials in Oncology.

Category:Medical associations